KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Goodwill (2016 - 2025)

Abbott Laboratories (ABT) has disclosed Goodwill for 17 consecutive years, with $24.0 billion as the latest value for Q4 2025.

  • Quarterly Goodwill rose 4.01% to $24.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $24.0 billion through Dec 2025, up 4.01% year-over-year, with the annual reading at $24.0 billion for FY2025, 4.01% up from the prior year.
  • Goodwill hit $24.0 billion in Q4 2025 for Abbott Laboratories, roughly flat from $24.0 billion in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $24.0 billion in Q4 2025 to a low of $22.3 billion in Q3 2022.
  • Historically, Goodwill has averaged $23.3 billion across 5 years, with a median of $23.3 billion in 2021.
  • Biggest five-year swings in Goodwill: decreased 4.29% in 2022 and later increased 4.38% in 2023.
  • Year by year, Goodwill stood at $23.2 billion in 2021, then decreased by 1.72% to $22.8 billion in 2022, then rose by 3.86% to $23.7 billion in 2023, then decreased by 2.41% to $23.1 billion in 2024, then rose by 4.01% to $24.0 billion in 2025.
  • Business Quant data shows Goodwill for ABT at $24.0 billion in Q4 2025, $24.0 billion in Q3 2025, and $24.0 billion in Q2 2025.